Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a <i>post-hoc</i> analysis.

Front Oncol · 2022 · PMC9780071 · PMID 36568164

Europe PMC DOI

hedged sentence

0.0721

closest p · 1.4× alpha

0.0721

boldest claim

The sentences

a clear trendp <0.0721so close (0.05 < p ≤ 0.1)

We also observed a clear trend towards longer PFS in patients with surgically free disease as compared to those with non-surgically free ( p <0.0721) ( Table 3 ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.